Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

Completed · Phase 2

Conditions studied: Open-angle Glaucoma, Ocular Hypertension

In brief

The purpose of this study is to compare the safety and IOP-lowering efficacy of various low dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00637130

Run by

Alcon Research

People needed

138

Starts

2007-10-01

Last updated by the study team

2012-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years of age or older, either sex or race with open-angle glaucoma or confirmed ocular hypertension
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• Age related
• Other protocol-defined exclusion criteria may apply

Where it is running

• Contact Alcon Call Center at 1-888-451-3937 — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.